Following encouraging research results, retatrutide, a new peptide therapy for addressing type 2 hyperglycemia , has secured regulatory approval from Great Britain's Medicines and Regulatory Agency ( https://ineskctx514961.bcbloggers.com/40027256/retatrutide-treatment-peptide-united-kingdom-approval-and-access